Peng, Wenjing
Yang, Fan
Li, Diliang
Zhao, Rui
Wan, Lijuan
Chen, Shuang
Liu, Xiangchun
Wang, Sicong
Li, Yuanlong
Li, Min
Liu, Yuan
Zhang, Hongmei https://orcid.org/0000-0002-6421-4126
Article History
Received: 3 June 2025
Accepted: 28 November 2025
First Online: 26 January 2026
Declarations
:
: This prospective study was approved by the institutional review board of the National Cancer Center (No. NCC2021C-456).
: Written informed consent was obtained from all participants.
: SCW, YLL, and ML were affiliated with GE Healthcare. They contributed to the application setup and clinical deployment of the deep learning reconstruction technology (AIRâ„¢ Recon DL), supporting its smooth implementation in this project. Importantly, they had no access to, nor did they exert any control over, patient recruitment, image acquisition, data analysis, or outcome evaluation. Other authors have no competing interests to declare.